INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0

CUSIP: 45845PAA6

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class
Debt / NOTE 3.250% 7/0
Total 13F principal
$0
Total 13F market value
$0
Principal change
-$9,719,000
Number of holders
0
Value change
-$10,109,022
Number of sells
4

Security key

45845PAA6

Report period

Q3 2023

Institutions

0

Top holders

0

45845PAA6 full security history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

There are no holders of INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0 as of Q3 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .